Politics
EPA flags microplastics, pharmaceuticals as contaminants in drinking water
The agency's recent announcement highlights growing public concern over health risks associated with these chemicals.
Editorial Staff Updated 14 days ago
#pharmaceuticals
18 articles tagged with "pharmaceuticals"
Life
Trump announces 100% tariffs on brand-name drugs, with plenty of carveouts
The taxes are part of the president's push to rein in the pharmaceutical industry and bring manufacturing to the U.S.
Editorial Staff Updated 15 days ago
Life
Briefing: Small Drugmakers Negotiate Pricing Deals Amid Tariff Threat
Strategic angle: The Trump administration is in talks with smaller pharmaceutical companies to establish new drug-pricing agreements.
Editorial Staff 15 days ago
Money
Briefing: Johnson & Johnson (JNJ) Benefits from Growth Pipeline and Strength Across Key Therapeutic Areas
Strategic angle: The company showcases robust growth prospects driven by its diverse therapeutic offerings.
Editorial Staff 17 days ago
Life
Briefing: Doctors Without Borders calls Gilead ‘unconscionable’ for refusing to sell HIV prevention drug
Strategic angle: The organization criticized Gilead Sciences after months of negotiations for a limited supply of lenacapavir.
Editorial Staff 18 days ago
Life
Briefing: Trump Pushes Drug Pricing Policy Amid Biotech Developments
Strategic angle: The White House shares legislative text on drug pricing with major pharmaceutical companies.
Editorial Staff 19 days ago
Life
Briefing: Understanding protein motion could greatly aid new drug design
Strategic angle: Exploring the dynamics of proteins may unlock new possibilities in pharmaceutical development.
Editorial Staff 21 days ago
Life
Iran war has not disrupted pharma supply chains. That could change if conflict is prolonged
The escalating war in the Middle East so far has not appreciably disrupted global pharmaceutical supply chains, but it could eventually — affecting prices.
Editorial Staff Updated 26 days ago
Life
Briefing: Maryland Legislator Proposes Bill for Pharma Transparency in Disease Awareness Campaigns
Strategic angle: A new bill aims to mandate drugmakers and patient groups to reveal their connections to disease awareness initiatives.
Editorial Staff about 1 month ago
Life
Briefing: J&J Wins Approval for First-of-its-Kind Psoriasis Pill
Strategic angle: Johnson & Johnson's new daily psoriasis pill offers benefits comparable to injectable treatments, potentially disrupting a multibillion-dollar market.
Editorial Staff about 1 month ago
Life
Briefing: Trump's Drug Pricing Moves and GSK Asthma Drug Insights
Strategic angle: The White House intensifies pressure on Congress for drug pricing legislation.
Editorial Staff about 1 month ago
Life
Briefing: Asthma patients suffered as GSK pursued ‘egregious’ price hikes, senator says
Strategic angle: Families report financial and treatment struggles after GSK's price increases on asthma inhalers.
Editorial Staff about 1 month ago
Life
Structure Therapeutics Reports Significant Weight Loss from Mid-Stage GLP-1 Pill
An experimental obesity pill from Structure Therapeutics helped patients lose significant weight in a mid-stage trial, with a Phase 3 study in the works.
Editorial Staff Updated about 1 month ago
Life
Good news for wastewater irrigation: Three crops store pharmaceutical byproducts in their leaves
Farmers in water-scarce areas can safely use treated wastewater for irrigation, as certain crops can absorb and store pharmaceutical byproducts.
Editorial Staff Updated about 1 month ago
Life
Briefing: Failed experiment leads to surprise drug development breakthrough
Strategic angle: Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than toxic chemicals.
Editorial Staff about 1 month ago
Money
Briefing: Tariffs, uncertainty and disruption: how drug makers and distributors can build operational supply chain resilience
Strategic angle: Exploring strategies for drug manufacturers and distributors to enhance supply chain resilience amidst tariffs and disruptions.
Editorial Staff about 1 month ago
Life
Briefing: Unlocking the hidden pocket on a billion‑dollar drug target
Strategic angle: Researchers discover new functions of the cereblon protein that could enhance cancer drug efficacy.
Editorial Staff about 1 month ago
Money
Servier's $2.5 Billion Acquisition of Day One: Strategic Implications
Servier's acquisition of Day One Biopharmaceuticals for $2.5 billion could reshape its position in the pediatric oncology market, but risks remain.
Editorial Staff about 1 month ago